Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis

Supportive Care in Cancer

Volumn 5, Issue 1, 1997, Pages 31-37

  Perez, Edith A ^a   Navari, Rudolph M ^b   Kaplan, Henry G ^c   Gralla, Richard J ^d   Grunberg, Steven M ^e   Palmer, Robert H ^f   Fitts, David ^f  

^a MAYO CLINIC   (United States)

^b Simon Williamson Clinic   (United States)

^c SWEDISH MEDICAL CENTER   (United States)

^d Ochsner Cancer Institute   (United States)

^e FLETCHER ALLEN HEALTH CARE   (United States)

^f Clinical Research   (United States)

Author keywords

Antiemetic therapy; Cancer chemotherapy; Cisplatin; Emesis; Granisetron

Indexed keywords

CISPLATIN; GRANISETRON;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0030893436     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01681959     Document Type: Article

References (23)

1. Addelman M, Erlichman C, Fine S (1990) Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting. J Clin Oncol 8:337-341
2. 3-antagonist, compared to alizapride plus dexamethasone as antiemetics during five-day-cycles of cytotoxic chemotherapy. Ann Oncol 1:110
3. Chevallier B (1990) Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. Eur J Cancer 26 [Suppl 1]:S33-S36
4. Cupissol DR, Serrou B, Caubel M (1990) The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis. Eur J Cancer 26 [Suppl 1]:S23-S27
5. DeMulder PHM, Seynaeve C, Vermorken JR, et al (1990) Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study. Ann Intern Med 113:834-840
6. Diehl V, on behalf of the Granisetron Study Group (1992) Fractionated chemotherapy - granisetron or conventional antiemetics? Eur J Cancer 28A [Suppl 1]:S22-S28
7. Falkson CL, Falkson HC (1995) Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapy. Oncology 52:427-131
8. 3-receptor antagonist. BRL 4369A, an agent for the prevention of chemotherapy-induced nausea and vomiting. Cancer Chemother Pharmacol 24:193-196
9. Gralla RJ, Itri L, Pisko SE, et al (1981) Antiemetic efficacy of high-dose metoclopramide. Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 305:905-909
10. Hainsworth J, Harvey W, Pendergrass K, et al (1991) A single-blind comparison of intravenous ondansetron with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. J Clin Oncol 9:721-728
11. Le Bonniec M, Marty M, Dieras V, et al (1990) Granisetron versus standard anti-emetics in the prophylactic treatment of chemotherapy-induced emesis (abstract). Proceedings of the 15th International Cancer Congress. Hamburg, Germany, SmithKline Beecham Satellite Symposium, p 35
12. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:515-519
13. Marschner NW, Adler M, Nagel GA, et al (1991) Double-blind randomized trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. Eur J Cancer 27:1137-1140
14. 3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. Eur J Cancer 26 [Suppl 1]:S28-S32
15. 3 receptor antagonist, in the prevention of nausea and vomitins induced by high-dose cisplatin. J Clin Oncol 12:2204-2210
16. Perez EA, Gandara DR (1994) The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis. Semin Oncol 21 [Suppl 5]:S15-S21
17. Riviere A, on behalf of the Granisetron Study Group (1994) Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. Br J Cancer 69:967-971
18. Schmoll HJ (1989) The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimens. Eur J Cancer 25 [Suppl 1]:S35-S39
19. Smith IE (1990) A comparison of two dose levels of granisetron in patients receiving moderately emetogenic cytostatic chemotherapy. Eur J Cancer 26 [Suppl 1]:S19-S23
20. Sorbe BG, Hogberg T, Glimelius B, et al (1995) Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group. Anticancer Drugs 6 [Suppl 1]:31-16
21. Soukop M (1990) A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. Eur J Cancer 26 [Suppl 1]:S15-S29
22. Stewart DJ (1990) Cancer therapy, vomiting, and antiemetics. Can J Physiol Pharmacol 68:304-313
23. Tabona MV (1990) An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy. Eur J Cancer 26 [Suppl 1]:S37-S41